ДОПОЛНЕНИЕ
СЛУГИ ТЕСТИРОВАНИЯ НА ВИЧ
ДЕКАБРЬ 2016 г.
Johnson CC et al. Journal of the International AIDS Society 2017, 20:21594 http://www.jiasociety.org/index.php/jias/article/view/21594 | https://doi.org/10.7448/IAS.20.1.21594
РУКОВОДСТВО ПО
ДОПОЛНЕНИЕ К СВОДНОМУ РУКОВОДСТВУ ПО УСЛУГАМ ТЕСТИРОВАНИЯ НА ВИЧ
ДЕКАБРЬ 2016 г.
УСЛУГИ ТЕСТИРОВАНИЯ НА ВИЧ
The Mtoto Mwerevu Stunting Reduction Toolkit is a resource for government and organisations involved in addressing stunting and broader nutrition issues in Tanzania. The toolkit was developed in conjunction with the Government of Tanzania (GoT) with funding from UK Aid as part of the Addressing Stun...ting in Tanzania Early (ASTUTE) programme. Its goal is to provide government, donors, non-governmental organisations, and civil society organisations (CSOs) with programming recommendations and tools to help implement successful multi-sectoral social and behaviour change (SBC) interventions aimed at preventing and reducing stunting.
more
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...n rural areas of low-income countries, making it difficult to identify and treat patients. Additionally, there is controversy about the role, type and duration of anthelmintic, antiinflammatory and antiepileptic drug (AED) treatments for different forms of neurocysticercosis.
These guidelines were developed to assist health-care providers in appropriate, evidence-based management of parenchymal neurocysticercosis. The guidelines do not address other forms of neurocysticercosis and do not include management of extraparenchymal disease (including cysticerci in the cerebral ventricles or subarachnoid space). The aim of the guidance is to improve decision-making to ensure appropriate patient care and to avoid misdiagnoses and inappropriate treatment of patients with neurocysticercosis.
more
A Snapshot of European Collection Schemes
Helping Adolescents Thrive (HAT) is a joint WHO-UNICEF initiative to strengthen programming and policy responses for adolescents, to promote positive mental health, prevent mental health conditions,
and prevent self-harm and other risk behaviours. The vision of HAT is a world in which all adolescen...ts, their caregivers, civil society and communities unite with governments to protect and promote adolescent mental health. This means taking action routinely to implement and monitor evidence-informed and human rights-based strategies for improving mental health, and to prevent and reduce mental health and substance use conditions in adolescents in order to improve lifelong well-being
more
Ayudar a los Adolescentes a Prosperar es una iniciativa conjunta OMS-UNICEF para fortalecer la programación y las respuestas políticas para los adolescentes con miras a promover su salud mental, prevenir trastornos en ese ámbito y evitar conductas
autolesivas y comportamientos de riesgo. La visi...ón de HAT es un mundo en el que todos los adolescentes, sus cuidadores, la sociedad civil y las comunidades se unan con los gobiernos para proteger y promover la salud mental de los adolescentes. Eso significa tomar medidas sistemáticas con las que aplicar y supervisar estrategias basadas en pruebas y respetuosas con los derechos humanos, para mejorar la salud mental y prevenir y reducir los trastornos en ese ámbito y los producidos por el consumo de sustancias adictivas entre los adolescentes con el fin de mejorar su bienestar de por vida
more
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...ess the emergency.
MAAP reviewed 819,584 AMR records from 2016-2019, from 205 laboratories across Burkina Faso, Cameroon, Eswatini, Gabon, Ghana, Kenya, Malawi, Nigeria, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, and Zimbabwe. MAAP also reviewed data from 327 hospital and community pharmacies and 16 national-level AMC datasets.
more